Antileishmanial and antitrypanosomal activities of the 8-aminoquinoline tafenoquine (Q34309401)

1 August 2017

Antileishmanial and antitrypanosomal activities of the 8-aminoquinoline tafenoquine (English)

1 reference

1 August 2017

Francisco Gamarro

2

0 references

author name string

Vanessa Yardley

series ordinal

1

1 reference

PubMed ID

20837750

1 August 2017

Simon L Croft

series ordinal

3

1 reference

PubMed ID

20837750

1 August 2017

language of work or name

English

0 references

publication date

13 September 2010

1 reference

Antimicrobial Agents and Chemotherapy

1 August 2017

1 reference

1 August 2017

54

1 reference

1 August 2017

12

1 reference

1 August 2017

5356-5358

1 reference

Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches

1 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981226

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981226

Deciphering the Leishmania exoproteome: what we know and what we can learn

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981226

Short-course paromomycin treatment of visceral leishmaniasis in India: 14-day vs 21-day treatment

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981226

Leishmaniases' burden of disease: ways forward for getting from speculation to reality

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981226

Antiparasitic activities and toxicities of individual enantiomers of the 8-aminoquinoline 8-[(4-amino-1-methylbutyl)amino]-6-methoxy-4-methyl-5-[3,4-dichlorophenoxy]quinoline succinate

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981226

Human African trypanosomiasis: pharmacological re-engagement with a neglected disease.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981226

8-Aminoquinolines: future role as antiprotozoal drugs

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981226

Miltefosine--discovery of the antileishmanial activity of phospholipid derivatives

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981226

Chemotherapy in the treatment and control of leishmaniasis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981226

In vitro and in vivo interactions between miltefosine and other antileishmanial drugs

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981226

Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981226

A comparison of the activities of three amphotericin B lipid formulations against experimental visceral and cutaneous leishmaniasis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981226

Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing beta-galactosidase

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981226

Potential use of WR6026 as prophylaxis against transfusion-transmitted American trypanosomiasis.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981226

A phase II dose-ranging study of sitamaquine for the treatment of visceral leishmaniasis in India.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981226

A phase II dose-increasing study of sitamaquine for the treatment of visceral leishmaniasis in Kenya

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981226

The activity against Trypanosoma cruzi and cutaneous leishmaniasis, and toxicity, of moxipraquine (349C59).

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981226

Evidence that certain 8-aminoquinolines are potentially effective drugs against Chagas disease

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2981226

Regulation of Leishmania populations within the host. I. the variable course of Leishmania donovani infections in mice

9 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20837750

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The antileishmanial activity of lepidines.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20837750

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.00985-10

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

PubMed ID

20837750